Ambulatory or hospitalized cirrhotic patients aged 40 years and over were recruited at 11 centers. Methods: A prospective, multicenter, cross‐sectional study was conducted.
The aim of the study was to define Tunisian norms for the test based on healthy controls norms and to estimate the prevalence of CHE in cirrhotic Tunisian patients.
The EncephalApp Stroop test is validated for its screening. 1 Gastroenterology, Mohamed Taher Maamouri Hospital, Tunis El Manar University, Faculty of Medicine of Tunis, Nabeul, Tunisia 2 Gastroenterology, Military Hospital of Tunis, Tunis El Manar University, Faculty of Medicine of Tunis, Tunis, Tunisia 3 Gastroenterology, Habib Bougatfa Hospital, Tunis El Manar University, Faculty of Medicine of Tunis, Bizerte, Tunisia 4 Gastroenterology, La Rabta Hospital A, Tunis El Manar University, Faculty of Medicine of Tunis, Tunis, Tunisia 5 Gastroenterology, Hedi Chaker Hospital, Faculty of Medicine of Sfax, Sfax, Tunisia 6 Gastroenterology, Fattouma Bourguiba University Hospital, Monastir, Monastir, Tunisia 7 Gastroenterology, La Marsa Internal Security Forces Hospital, Tunis El Manar University, Faculty of Medicine of Tunis, Tunis, Tunisia 8 Gastroenterology, Habib Thameur Hospital, Tunis El Manar University, Faculty of Medicine of Tunis, Tunis, Tunisia 9 Gastroenterology, Hospital Charles Nicolle, Tunis, Tunis El Manar University, Faculty of Medicine of Tunis, Tunis, Tunisia 10 Gastroenterology, Jendouba Hospital, Jendouba, Tunisia 11 Gastroenterology, Kasserine Hospital, Kasserine, Tunisiaīackground: Covert hepatic encephalopathy (CHE) is underdiagnosed and is difficult to detect.
0 kommentar(er)
